# Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 Diabetics

> **NCT01645696** · NA · COMPLETED · sponsor: **Becton, Dickinson and Company** · enrollment: 30 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DEVICE:** BD CGM with Outer Layer
- **DEVICE:** BD CGM without Outer Layer
- **DEVICE:** Medtronic iPro2 Professional CGM

## Key facts

- **NCT ID:** NCT01645696
- **Lead sponsor:** Becton, Dickinson and Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01645696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01645696, "Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 Diabetics". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01645696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*